Paracet 500 mg tablets

Paracet is one of the most recognized over-the-counter medication brands in Norway, primarily used for pain relief and fever reduction. The brand was originally developed and popularized by the Norwegian pharmaceutical company Weifa AS. For decades, it has been a staple in Norwegian households, known for its orange and white packaging and the active ingredient paracetamol.

Over the years, the ownership of the brand has transitioned through major corporate acquisitions. In 2017, Weifa was acquired by Karo Pharma (now Karo Healthcare), a Swedish-based healthcare company. As a result, while the brand maintains its deep Norwegian heritage and continues to be associated with its original headquarters in Oslo, it is now part of a larger Nordic corporate structure. Manufacturing has historically been centered in Norway, though global supply chains for active pharmaceutical ingredients are common in the industry.

Today, Karo Healthcare, the ultimate owner, manages a broad portfolio of everyday healthcare brands across Europe. The company is backed by the private equity firm EQT, positioning Paracet as a key asset in a multi-national healthcare conglomerate while it retains its status as Norway's market-leading paracetamol brand.